INCREASED SERUM APOLIPOPROTEIN(A) IN PATIENTS WITH CHRONIC-RENAL-FAILURE TREATED WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS

被引：31
|
作者：
MURPHY, BG
MCNAMEE, P
DULY, E
HENRY, W
ARCHBOLD, P
TRINICK, T
机构：
[1] BELFAST CITY HOSP,DEPT MED,BELFAST BT9 7AD,ANTRIM,NORTH IRELAND
[2] BELFAST CITY HOSP,DEPT CLIN CHEM,BELFAST BT9 7AD,ANTRIM,NORTH IRELAND
[3] ULSTER HOSP,BELFAST,NORTH IRELAND
来源：
ATHEROSCLEROSIS | 1992年 / 93卷 / 1-2期
关键词：
CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD); APOLIPOPROTEIN(A); LIPOPROTEIN(A); CHOLESTEROL;
D O I：
10.1016/0021-9150(92)90199-Q
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Patients with end-stage renal failure (ESRF) on renal replacement therapy are at significantly increased risk of cardiovascular disease. To determine whether altered concentrations of apolipoprotein(a) (apo(a)), the plasminogen-like protein moiety of the atherogenic particle lipoprotein(a), contributed to this increased risk, apo(a) concentrations were measured in 48 non-diabetic patients with ESRF treated by continuous ambulatory peritoneal dialysis (CAPD) therapy and compared with 65 controls. Apo(a) concentration was increased in CAPD patients compared to controls (geometric mean 419 units/l versus 137 units/l; ratio of means 3.06 (95% CI 1.95-4.80). We conclude that CAPD patients have increased apo(a) concentrations which may contribute to their increased risk of cardiovascular disease.
引用
收藏
页码：53 / 57
页数：5
相关论文
共 50 条
  • [1] POLYCYTHEMIA IN A PATIENT WITH CHRONIC-RENAL-FAILURE TREATED BY CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    RAGNAUD, JM
    VALLOT, C
    WONE, C
    [J]. PRESSE MEDICALE, 1984, 13 (23): : 1458 - 1459
  • [2] THE TREATMENT OF CHRONIC-RENAL-FAILURE BY AMBULATORY CONTINUOUS PERITONEAL-DIALYSIS
    BENEVENT, D
    RINCE, M
    LEROUXROBERT, C
    [J]. GAZETTE MEDICALE DE FRANCE, 1982, 89 (13): : 1463 - &
  • [3] TREATMENT OF CHRONIC-RENAL-FAILURE WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    NAICKER, S
    RAWAT, R
    SEEDAT, YK
    SMITH, C
    [J]. KIDNEY INTERNATIONAL, 1980, 18 (04) : 533 - 533
  • [4] TREATMENT OF CHRONIC-RENAL-FAILURE BY CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    FALLER, B
    MARICHAL, JF
    [J]. JOURNAL DE MEDECINE DE STRASBOURG, 1980, 11 (06): : 344 - 346
  • [5] IMPACT OF CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS ON TREATMENT OF CHRONIC-RENAL-FAILURE
    GOVANTES, MAG
    PEREIRA, P
    PARRILLA, JG
    ALGARRA, GR
    MARTIN, C
    CACHO, M
    RAMOS, M
    MATEOS, J
    [J]. NEFROLOGIA, 1984, 4 (01): : 49 - 58
  • [6] CONTINUOUS PERITONEAL-DIALYSIS FOR CHRONIC-RENAL-FAILURE
    LEVEY, AS
    HARRINGTON, JT
    [J]. MEDICINE, 1982, 61 (05) : 330 - 339
  • [7] LOW SERUM CA125 CONCENTRATION IN CHRONIC-RENAL-FAILURE TREATED WITH CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    KAWABE, T
    ISHII, M
    SUGIMOTO, T
    TAGAWA, H
    [J]. CLINICA CHIMICA ACTA, 1987, 168 (01) : 113 - 114
  • [8] GASTRIC-EMPTYING IN PATIENTS WITH CHRONIC-RENAL-FAILURE ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    BIRD, NJ
    STREATHER, CP
    ODOHERTY, MJ
    BARTON, IK
    GAUNT, JI
    NUNAN, TO
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (03) : 287 - 290
  • [9] EXERCISE CAPACITY IN CHRONIC-RENAL-FAILURE PATIENTS MANAGED BY CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    BEASLEY, CRW
    SMITH, DA
    NEALE, TJ
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1986, 16 (01): : 5 - 10
  • [10] HYPERAPOBETALIPOPROTEINEMIA - THE MAJOR DYSLIPOPROTEINEMIA IN PATIENTS WITH CHRONIC-RENAL-FAILURE TREATED WITH CHRONIC AMBULATORY PERITONEAL-DIALYSIS
    SNIDERMAN, A
    CIANFLONE, K
    KWITEROVICH, PO
    HUTCHINSON, T
    BARRE, P
    PRICHARD, S
    [J]. ATHEROSCLEROSIS, 1987, 65 (03) : 257 - 264
12345